Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Emerald Bioventures, LLC - 15 May 2026 SCHEDULE 13D/A Report for Galera Therapeutics, Inc. Common stock, par value $0.001 per share (the "Common Stock") (GRTX)
- Filing manager
- Emerald Bioventures, LLC
- Reporting owner
- Emerald Bioventures, LLC
- Beneficially owned shares
- 61,029,978 shares
- Class ownership
- 30%
- Large-stake signal
-
Ownership
30%Beneficial ownership of this reported class.
Shares
61,029,978 sharesShares beneficially owned as disclosed.
Event date
15 May 2026Date tied to the ownership event or amendment.
Accepted by SEC
29 May 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Symbol
- GRTX
- Shares outstanding
- 202,086,020 shares
- Form type
- SCHEDULE 13D/A
- Accepted by SEC
- 29 May 2026, 16:58:26 UTC
- Event date
- 15 May 2026
- Previous filing
- 27 Apr 2026
- SEC filing
- View on sec.gov
Ownership signal
2 signals
Subject security
2 source fields
Source evidence
5 source fields
Key filing fact
Emerald Bioventures, LLC disclosed 30% ownership in Galera Therapeutics, Inc. Common stock, par value $0.001 per share (the "Common Stock") (GRTX) on 15 May 2026.
Key facts
- Emerald Bioventures, LLC filed SCHEDULE 13D/A for Galera Therapeutics, Inc. Common stock, par value $0.001 per share (the "Common Stock") (GRTX).
- Disclosed ownership: 30%.
- Date of event: 15 May 2026.
Change
- Previous schedule filing date: 27 Apr 2026.
- Current filing was accepted on 29 May 2026, 16:58.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (2)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Emerald Bioventures, LLC | 30% | 61,029,978 | 0 | 61,029,978 | /s/ Timothy Opler | Timothy Opler, Managing Member | 0002020620 |
| Timothy Opler | 30% | 61,029,978 | 0 | 61,029,978 | /s/ Timothy Opler | Timothy Opler | 0001706867 |
CIK / CUSIP context first